Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Introduction
  • Methods
  • Results
  • Discussion
  • Acknowledgments
  • References
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Article Free access | 10.1172/JCI5073

Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes

H. Bradley Nuss, Eduardo Marbán, and David C. Johns

Section of Molecular and Cellular Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA

Address correspondence to: Eduardo Marbán, Section of Molecular and Cellular Cardiology, The Johns Hopkins University School of Medicine, 844 Ross Building, 720 N. Rutland Avenue, Baltimore, Maryland 21205, USA. Phone: (410) 955-2776; Fax: (410) 955-7953; E-mail: marban@welchlink.welch.jhu.edu

Find articles by Nuss, H. in: JCI | PubMed | Google Scholar

Section of Molecular and Cellular Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA

Address correspondence to: Eduardo Marbán, Section of Molecular and Cellular Cardiology, The Johns Hopkins University School of Medicine, 844 Ross Building, 720 N. Rutland Avenue, Baltimore, Maryland 21205, USA. Phone: (410) 955-2776; Fax: (410) 955-7953; E-mail: marban@welchlink.welch.jhu.edu

Find articles by Marbán, E. in: JCI | PubMed | Google Scholar

Section of Molecular and Cellular Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA

Address correspondence to: Eduardo Marbán, Section of Molecular and Cellular Cardiology, The Johns Hopkins University School of Medicine, 844 Ross Building, 720 N. Rutland Avenue, Baltimore, Maryland 21205, USA. Phone: (410) 955-2776; Fax: (410) 955-7953; E-mail: marban@welchlink.welch.jhu.edu

Find articles by Johns, D. in: JCI | PubMed | Google Scholar

Published March 15, 1999 - More info

Published in Volume 103, Issue 6 on March 15, 1999
J Clin Invest. 1999;103(6):889–896. https://doi.org/10.1172/JCI5073.
© 1999 The American Society for Clinical Investigation
Published March 15, 1999 - Version history
Received: August 31, 1998; Accepted: February 9, 1999
View PDF
Abstract

The high incidence of sudden death in heart failure may reflect abnormalities of repolarization and heightened susceptibility to arrhythmogenic early afterdepolarizations (EADs). We hypothesized that overexpression of the human K+ channel HERG (human ether-a-go-go-related gene) could enhance repolarization and suppress EADs. Adult rabbit ventricular myocytes were maintained in primary culture, which suffices to prolong action potentials and predisposes to EADs. To achieve efficient gene transfer, we created AdHERG, a recombinant adenovirus containing the HERG gene driven by a Rous sarcoma virus (RSV) promoter. The virally expressed HERG current exhibited pharmacologic and kinetic properties like those of native IKr. Transient outward currents in AdHERG-infected myocytes were similar in magnitude to those in control cells, while stimulated action potentials (0.2 Hz, 37°C) were abbreviated compared with controls. The occurrence of EADs during a train of action potentials was reduced by more than fourfold, and the relative refractory period was increased in AdHERG-infected myocytes compared with control cells. Gene transfer of delayed rectifier potassium channels represents a novel and effective strategy to suppress arrhythmias caused by unstable repolarization.

Introduction

The delayed rectifier potassium current (IK) is critical for normal repolarization in the heart. It represents the sum of two components that are kinetically, pharmacologically, and genetically distinct. The faster component, designated IKr, is blocked selectively by class III antiarrhythmic drugs such as dofetilide, E-4031, dl-sotalol, and MK-499 (1). Putative genes have been identified for both components of IK: the human ether-a-go-go-related gene (HERG) (2–4) encodes IKr channels, while KvLQT1 (5, 6) encodes the major subunit of the slower IKs channels. Both IKr and IKs are regulated by an accessory protein encoded by the minK gene. When expressed heterologously, minK increases the number of functional channels at the cell-surface membrane and, at least in the case of IKs, modifies the kinetics of the current to more closely mimic its endogenous counterpart (7).

Genetic and pharmacologic misfortunes have helped underscore the importance of HERG/IKr for normal repolarization and suppression of lethal ventricular arrhythmias. Naturally occurring mutations in HERG, producing nonfunctional channels and reduced current, underlie the chromosome 7–linked form of long Q-T syndrome (8–12). Afflicted individuals demonstrate prolonged Q-T intervals and experience sporadic arrhythmias, placing them at risk for sudden cardiac death. Administration of seemingly benign noncardiac prescription drugs, such as the antihistamine terfenadine (13, 14) and the prokinetic agent cisapride (15, 16), have been responsible for the initiation of lethal arrhythmias. Both compounds are capable of prolonging the Q-T interval and inducing torsades de pointes in susceptible individuals through their potent blocking action on IKr (17, 18).

To date, the role of IKr in repolarization has been probed only by using IKr-specific blockers (19) and through various quantitative simulations (20–22). The primary goal of this study was to advance our understanding of the importance of IKr for normal cardiac repolarization and suppression of ventricular arrhythmias. The strategy was to determine the functional consequences of HERG overexpression on cardiac excitability through direct experimentation. HERG overexpression was achieved in adult rabbit ventricular myocytes in primary culture using adenovirally mediated gene transfer. Genetically increasing HERG current in myocytes shortens action potential duration, decreases susceptibility to early afterdepolarizations (EADs), and increases the refractory period.

Methods

Isolation and primary culture of rabbit ventricular myocytes. Rod-shaped myocytes were isolated from the left ventricles of normal rabbits via enzymatic digestion of the whole heart on a Langendorff apparatus, using common cell isolation techniques (23). Animals were euthanized by pentobarbital overdose (80 mg/kg intravenously). Hearts were rapidly excised and rinsed in a modified Tyrode's solution and then mounted on a Langendorff apparatus. The coronaries were perfused retrogradely with the following four solutions in sequential order: 1 mM Ca Tyrode's (2 min), Ca-free Tyrode's (6.5 min), Ca-free Tyrode's containing collagenase (Worthington type IV) and protease (Sigma Chemical Co., St. Louis, Missouri, USA) (8 min), and 0.1 mM Ca Tyrode's (2 min). When the heart tissue became flaccid, the left ventricle was dissected free and mechanically dissociated to release individual myocytes. The freshly isolated myocytes were gently centrifuged and resuspended in standard culture medium: Medium M199 with Earl's salts and L-glutamine (Cellgro; Mediatech Inc., Herndon, Virginia, USA), supplemented with penicillin (PCN-K+, 50 U/ml; Sigma Chemical Co.) and 2% FBS (HyClone Laboratories, Logan, Utah, USA). Myocytes were suspended to a final concentration of 5 × 104 cells/ml and plated onto laminin-coated coverslips (20 μl/ml; Sigma Chemical Co.). Cells were maintained at 37°C in a humidified atmosphere of 5% CO2 and 95% air.

Adenovirus vector construction. The HERG adenovirus vector was engineered and constructed following established methods (24). Briefly, the full-length coding sequence of the HERG potassium channel (2–4) (provided by M. Keating, University of Utah, Salt Lake City, Utah, USA) was subcloned into our adenoviral shuttle vector (pEIRSV) (24). The bacterial plasmid pJM17, incorporating the full-length adenovirus 5 genome and the plasmid shuttle vector containing the HERG insert, was cotransfected into HEK 293 cells. Homologous recombination between pJM17 and the shuttle vector resulted in a replication-deficient recombinant adenovirus (AdHERG), with the HERG gene insert replacing the native viral early region 1 between map units 1.0 and 9.8. A control reporter adenovirus (AdGFP) was constructed that encodes the mitochondrially targeted green fluorescent protein (25) with the S65T point mutation for enhanced fluorescence (26).

Infection of myocytes. As described previously (27), ventricular myocytes isolated and maintained in primary culture for 12–18 h were infected (5–20 moi) with AdHERG and AdGFP, AdGFP alone, or left noninfected. Expression of the virally transduced HERG currents began to appear above the background native currents within 24 h after infection and further increased in size by 48 h.

Electrophysiology. All electrical recordings were made 36–72 h after the isolation of the myocytes using standard whole-cell voltage clamp recording methods (28). Pipettes had tip resistances of 2–4 MΩ when filled with a solution comprised of: 125 mM K-glutamate, 15 mM KCl, 5 mM NaCl, 1 mM MgCl2, 4 mM MgATP, and 10 mM HEPES, with pH adjusted to 7.3 with KOH. The modified Tyrode's recording solution used in these experiments was comprised of: 135 mM NaCl, 4 mM KCl, 1 mM MgCl2, 10 mM dextrose, 10 mM HEPES, and 2 mM CaCl2, with pH adjusted to 7.3 with NaOH. In some experiments, the methanesulfonanilide class III antiarrhythmic agent E-4031 (Eisai Co., Tokyo, Japan) was used to selectively block HERG/IKr current (1). All experiments were performed at body temperature (37°C) to characterize the electrophysiology of the cloned channels under physiologic conditions. Macroscopic current–voltage relations were measured from depolarizing voltage steps (500 ms) to potentials between –70 mV and +60 mV from a holding potential of –80 mV. The voltage dependence of activation was determined from tail currents measured upon repolarization to –100 mV.

Statistical analysis. Pooled data are presented as means ± SE. Comparison of measurements between groups were performed using a Student's t test. Differences in the data were considered statistically significant when P < 0.05.

Results

The overriding goal of this study was to test the hypothesis that the expression level of HERG/IKr dictates the repolarization properties and susceptibility to EADs of ventricular myocytes. We have previously demonstrated the utility of adenoviral gene transfer for introducing a foreign potassium channel gene (Drosophila Shaker B) into living heart cells in culture (27). We have now used the same approach to probe the physiologic consequences of overexpression of IKr using adenovirally mediated gene transfer of HERG.

Prolonged action potentials and susceptibility to EADs in cultured myocytes. Similar to the development of electrophysiologic alterations in heart failure, the expression levels and/or function of specific ion channels also change when adult ventricular myocytes are maintained in culture. After several days in primary culture, rabbit ventricular myocytes exhibit a decreased level of expression of potassium currents that govern repolarization (29). The changes in ionic currents may be related to abnormal turnover of these membrane ion channels in a nonphysiological neural and hormonal environment.

Action potentials (APs) in myocytes isolated from the left ventricle of the rabbit and maintained in primary culture for 48 hours (Fig. 1b) are noticeably prolonged compared with APs recorded in freshly isolated myocytes (Fig. 1a). Additionally, we observed an increased susceptibility to EADs in the cultured myocytes (Fig. 1b). Both phenomena are likely due to the general downregulation of potassium channels that occurs in culture (29).

Electrical recordings on isolated myocytes at 37°C indicate that compared wFigure 1

Electrical recordings on isolated myocytes at 37°C indicate that compared with freshly isolated myocytes (a) AP repolarization is delayed in rabbit ventricular myocytes maintained in primary culture for 48 h (b). Cultured myocytes also exhibited frequent early afterdepolarizations (b, right) that were not observed normally in freshly isolated myocytes. AP, action potential.

Phenotype of adenovirally expressed HERG current. IKr is important for repolarization in the heart in a number of species, including humans. In addition to the genetic evidence for its role in long Q-T syndrome, IKr-specific blockers are known to prolong ventricular AP (1, 30, 31) and facilitate EADs (32, 33). It is likely that HERG encodes the primary component of IKr channels as a heterologous expression of HERG in conventional expression systems, which otherwise lack appreciable membrane currents, resulting in currents very similar but not identical to IKr (34). As shown in Fig. 2, robust HERG currents were recorded in AdHERG-infected Chinese hamster ovary (CHO) cells. Noninfected CHO cells lack any appreciable endogenous currents (not shown). At room temperature, the kinetics of activation during depolarization are slow, while the large tail currents elicited upon repolarization to hyperpolarized potentials demonstrate rapid recovery of HERG channels from fast inactivation and subsequent deactivation. The average peak outward HERG current density measured by a voltage step to +20 mV equaled 5.2 ± 1.4 pA/pF (Fig. 2c, open bar; n = 6). Inward tail currents elicited upon immediate repolarization to –100 mV equaled –31.5 ± 4.3 pA/pF (Fig. 2c, filled bar; n = 6).

Virally transduced HERG current in CHO-K1 cells. Whole-cell currents recordFigure 2

Virally transduced HERG current in CHO-K1 cells. Whole-cell currents recorded at 22°C in CHO-K1 cells 36 h after infection with AdHERG. Currents recorded by families of step depolarizations on pulse 1 (a) and pulse 2 (b) demonstrate the characteristic behavior of HERG current. Increasing the size of the depolarizing voltage step speeds activation and causes rectification of HERG current (a). Changing the repolarization potential following a step to +20 mV demonstrates recovery from inactivation of channels at hyperpolarized voltages as well as reversal of HERG current near the K+ equilibrium potential (b). (c) Summary data indicate the average density of the outward current at +20 mV during pulse 1 (open bar) and inward current upon repolarization to –100 mV (filled bar, n = 6).

The virally expressed HERG channels behave identically to native IKr (Fig. 3), exhibiting modulation by extracellular K+ concentration (35–37), and block by the methanesulfonanilide class III antiarrhythmic agent E-4031 (38, 39) and the trivalent cation lanthanum (35). As shown in Fig. 3a, increasing K+ concentration in the recording solution from 4 mM to 8 mM increased HERG current amplitude and slowed the decay of the tail currents upon repolarization. In AdHERG-infected cardiac myocytes, the contribution of HERG current to the net membrane current elicited by a slow voltage ramp is revealed after exposure to E-4031 (5 μM; Fig. 3b) (1) or lanthanum (10 μM; Fig. 3c).

Modulation of virally expressed HERG current by extracellular K+ (a) and blFigure 3

Modulation of virally expressed HERG current by extracellular K+ (a) and block by E-4031 (b) or lanthanum (c). (a) Increasing extracellular K+ from 4 mM to 8 mM increased the magnitude of HERG current recorded in AdHERG-infected myocytes (1 and 2; 2-s depolarizations) and slowed the decay of HERG tail current elicited upon repolarization to –100 mV (1 and 3). Net membrane current recorded in response to a voltage ramp (+60 mV to –120 mV, 2 s) exhibits outward HERG current that is blocked by 5 μM E-4031 (b) or 10 μM lanthanum (c).CHO, Chinese hamster ovary.

HERG overexpression increases maintained outward current. Activation of HERG current in a cardiac background is more difficult to distinguish than in CHO-K1 cells, because the calcium-independent transient outward K+ current (Ito1) activates rapidly and overlaps with HERG at positive potentials. Figure 4 shows examples of the baseline currents in rabbit ventricular myocytes in culture and in an AdHERG-infected cell upon depolarization to +20 mV (Fig. 4, a and b) or +60 mV (Fig. 4, d and e). A prominent Ito1 and INa appear in both noninfected and AdHERG-infected cells. At 36–48 hours after infection the level of sustained current elicited by a voltage step to +20 mV (500 ms) in AdHERG-infected myocytes (5.3 ± 2.1 pA/pF; n = 10) is more than fivefold greater (P < 0.05) than in noninfected or AdGFP-infected myocytes (0.8 ± 0.3 pA/pF; n = 9) (Fig. 4c). In tail current measurements, the half activation potential for IKr in AdHERG-infected rabbit ventricular myocytes equaled 5 ± 1 mV (n = 10). Activation of HERG current was similar to the activation of IKr in noninfected and AdGFP-infected myocytes (3 ± 4 mV; n = 9). The steady-state current–voltage relationships measured at500 ms by a step depolarization in noninfected and AdGFP-infected cells show predominately the level of sustained Ito1 current primarily at potentials beyond 0 mV. In AdHERG-infected cells, activation of HERG current begins at –10 mV and then dominates the I-V relationship at positive voltages. The magnitude of sustained current is largest at +20 mV with the characteristic rectification of HERG (and IKr) current decreasing the sustained current at +30 mV and beyond.

Maintained outward current at +20 mV is increased, and transient outward K+Figure 4

Maintained outward current at +20 mV is increased, and transient outward K+ current is unchanged in AdHERG-infected myocytes. (a) Membrane currents elicited by a voltage step to +20 mV in noninfected and AdGFP-infected rabbit ventricular myocytes exhibit the characteristic INa spike followed by a large Ito1. (b) The decay of Ito1 is masked by the sustained level of HERG current in HERG-overexpressing myocytes. (c) On average, the level of sustained current was increased fivefold in AdHERG-infected myocytes (filled bar, n = 9) compared with controls (open bar, n = 10). Membrane current recordings obtained at +60 mV show the rapid activation and inactivation of Ito1 in noninfected and AdGFP-infected (d) and AdHERG-infected myocytes (e). The decay of current in AdHERG-infected myocytes is similar to that in controls because of the strong rectification of HERG current at positive potentials. (f) Average peak Ito1 current density was not significantly altered in AdHERG-infected myocytes (n = 9) compared with controls (open bar, n = 10).

Expression in cardiac cells accelerates the decay of HERG tail current. The kinetics of HERG current expressed in cardiac myocytes more closely resembles endogenous IKr than recordings of HERG expressed in mammalian cell lines. A direct comparison of the HERG current recordings obtained in CHO-K1 cells at 22°C (Fig. 2b) to those in rabbit ventricular myocytes at 37°C (Fig. 4, b and e) suggested that the increased temperature and/or expression in ventricular myocytes accelerates decay of the tail currents. Inward HERG tail currents were examined in detail by fitting a single exponential decay function to the tail current recorded upon repolarization to –100 mV following depolarization to –20 mV. Tail current kinetics were compared for HERG channels expressed in CHO-K1 cells at room temperature, cardiac myocytes at room temperature, and cardiac myocytes at body temperature. The results indicate that expression in a cardiac background accelerated the decay of HERG tail current independent of temperature: the time constant of decay equaled 211 ± 48 ms in CHO-K1 cells at 22°C (n = 6) versus 116 ± 18 ms in myocytes at 22°C (n = 9, P = 0.04). For HERG channels expressed in cardiac myocytes, increasing the temperature to 37°C additionally accelerated the decay of the tail currents to 9 ± 1 ms (n = 10, P < 0.01).

Selective overexpression of HERG. Adult rabbit ventricular myocytes infected with the HERG adenovirus exhibit selective overexpression of HERG current without net effects on the expression of other K+ channels. The magnitude of the early peak outward current in noninfected and AdGFP-infected control cells, which is largely contributed by Ito1 and has been shown to be reduced in heart failure (40), is similar in amplitude to that in AdHERG-overexpressing cells (Fig. 4, d and e). Comparison of the peak early outward current elicited upon depolarization to +60 mV in noninfected cells and cells infected with AdGFP (17.6 ± 2.3 pA/pF; n = 9), to those measured in AdHERG-infected cells (14.7 ± 3.0 pA/pF; n = 10), indicates that the endogenous early outward K+ current is not significantly altered by AdHERG infection (Fig. 4f). The peak early current–voltage relationships measured between –70 mV and +60 mV for noninfected, AdGFP-infected, and AdHERG-infected myocytes have similar shapes and current densities over the range of potentials tested (not shown).

Sensitivity of HERG to block by E-4031. The virally expressed HERG current is effectively blocked by E-4031, a potent blocker of endogenous IKr current (1) (Fig. 5). We assessed steady-state block by measuring the peak outward tail current elicited upon repolarization to –40 mV after a 500 millisecond step to +20 mV (Fig. 5a). Based on these tail current measurements, E-4031 exhibited an IC50 of 123 ± 11 nM (n = 12) for block of HERG current expressed in cardiac myocytes (Fig. 5b). The sensitivity of HERG channels overexpressed in rabbit ventricular cells to block by E-4031 compares favorably to published IC50 values for block of native IKr current in guinea pig and ferret cardiac myocytes (1, 41). At these low concentrations, E-4031 is selective for IKr (1, 42) and exogenously expressed HERG current (39). The summary data in Figure 5c compares the magnitude of the E-4031–sensitive tail currents (1–3 μM E-4031) in AdHERG-infected cells (3.6 ± 1.7 pA/pF; n = 17) to that in noninfected and AdGFP-infected control cells (0.3 ± 0.1 pA/pF; n = 7). HERG overexpression induced a 10-fold increase in the E-4031–sensitive current in AdHERG-infected myocytes compared with controls.

(a) Block of HERG current by the IKr-specific blocker E-4031 was assessed fFigure 5

(a) Block of HERG current by the IKr-specific blocker E-4031 was assessed from the amplitude of the peak outward tail current elicited upon repolarization to –40 mV in AdHERG-infected rabbit ventricular myocytes. (b) The IC50 for steady-state E-4031 block of HERG expressed in myocytes equals 123 ± 11 nM (n = 12). (c) Based on tail current measurements, the E-4031–sensitive current (1–3 μM) is 10-fold larger in AdHERG-infected myocytes (filled bar, n = 17) compared with controls (open bar, n = 7).

Effects of HERG overexpression on repolarization. The effects of HERG overexpression on cardiac excitability were examined by stimulating APs in rabbit ventricular myocytes with varying levels of expression of HERG current. We found that HERG overexpression abbreviated the rabbit ventricular AP without adversely modifying the normal AP waveform. As shown in Figure 6a, APs stimulated at 0.2 Hz were shortened significantly (P < 0.01) by HERG overexpression. The summary data (Fig. 6b) compare AP duration at 90% repolarization (APD90) in AdHERG-infected cells (195 ± 60 ms; n = 18) with noninfected and AdGFP-infected control cells (672 ± 132 ms; n = 12); APD90 is shortened by 70% on average by HERG overexpression. In fact, we observed that APs are abbreviated as a function of the level of HERG current overexpression. In Fig. 6c, linear regression analysis shows a positive correlation (P < 0.02) between APD90 and the level of current in AdHERG-infected cells (filled circles; n = 17). The current–voltage relationships recorded in this manner have a prominent N shape in AdHERG-infected cells. Although the correlation between APD90 and current density in noninfected and control myocytes (Fig. 6c, open squares; n = 12) did not attain significance (P = 0.10), it did indicate the maximal effect of HERG overexpression on abbreviating the AP, which is borne out in the AdHERG-infected data.

HERG overexpression abbreviates APD. (a) Early (phase 2) and late (phase 3)Figure 6

HERG overexpression abbreviates APD. (a) Early (phase 2) and late (phase 3) repolarization is enhanced in AdHERG-infected myocytes compared with noninfected and AdGFP-infected control cells. (b) APD measured at 90% repolarization was shortened by 70% on average by HERG overexpression (filled bar) compared with controls (open bar). (c) Regression analysis indicates a positive correlation (P < 0.02) between APD and the magnitude of current recorded at 0 mV by voltage ramp (+60 mV to –120 mV, 1 s) in AdHERG-infected myocytes (filled circles; n = 17). Regression analysis of data collected in noninfected and AdGFP-infected myocytes (open squares; n = 12) did not correlate significantly (P = 0.10). APD, action potential duration.

Effects of HERG overexpression on susceptibility to EADs. Alterations in K+ current expression, regardless of the cause, have a profound impact on repolarization and susceptibility to EADs. The increased susceptibility to EADs in failing canine ventricular myocytes is associated with the downregulation of Ito1 and IK1 that occurs from chronic tachycardia pacing (43). We examined whether the changes in K+ current expression that occur in rabbit cardiac myocytes over time in culture would make repolarization unstable. The short segments of APs shown in Figure 7 illustrate that during continuous stimulation the incidence of EADs in noninfected myocytes maintained in primary culture was high and that phase 2 EADs often recurred during the same AP. After the initiation of an EAD, the AP waveform became complex, with an unstable plateau between –20 mV and +10 mV. APs recorded under identical conditions in HERG-overexpressing myocytes rarely exhibited EADs. The frequency of EADs in noninfected and AdGFP-infected control cells (0.40 ± 0.17 EADs/AP; n = 7) was reduced fivefold by HERG overexpression (0.09 ± 0.05 EADs/AP; n = 12, P < 0.05). Repolarization in AdHERG-infected cells appears normal and these APs more closely resemble APs recorded in freshly isolated myocytes. The summary data indicate how effectively HERG overexpression suppresses EADs. Overexpression of HERG in cultured canine ventricular myocytes had similar effects: abbreviation of APs and suppression of EADs (n = 13, data not shown).

HERG overexpression suppresses EADs. (a) Noninfected and AdGFP-infected myoFigure 7

HERG overexpression suppresses EADs. (a) Noninfected and AdGFP-infected myocytes (n = 7) exhibit frequent and complex EADs during trains of continuously stimulated APs (0.2 Hz., 37°C). (b) In contrast, APs stimulated in AdHERG-infected myocytes (n = 12) repolarize normally. The summary data indicate the ratio of APs with an EAD (or multiple EADs) to the total number of APs in a stimulus train comprised of at least 10 APs. HERG overexpression significantly reduced the frequency of EADs (P < 0.05). EADs, early afterdepolarizations.

Effects of HERG overexpression on the refractory period. We were motivated to examine the effect of HERG overexpression on the effective refractory period (ERP) because we observed afterhyperpolarizations in cells with high levels of HERG current and because nicorandil, a K+ channel opener, provides increased protection against premature stimuli in long Q-T syndrome patients by prolonging the ERP (44). It has also been suggested that HERG may guard against premature beats because of its unique gating properties (45). Currents that figure prominently in determining the ERP have important implications in determining the recovery of excitability in the ventricle. To establish whether the level of expression of HERG K+ channels helps determine the refractory period in myocytes, APs were stimulated at a constant rate (0.5 Hz), and a premature suprathreshold stimulus (115% of threshold) was interposed at varying intervals during a period of continuous stimulation. The coupling interval of the extrastimulus was increased until a premature AP was evoked.

The ERP is defined as the longest coupling interval that fails to evoke an AP. However, to distinguish changes in APD from changes in ERP, the relative refractory period (RRP) was measured from the APD90 of the first AP to the time of the premature stimulus that elicits a second AP. As defined, changes in refractory period are compared between control and AdHERG-infected cells independent of the APD shortening that occurs via HERG overexpression.

In AdGFP-infected cells, a second AP with a normal waveform could be elicited almost immediately upon repolarization to resting potential (Fig. 8). In contrast, in the AdHERG-infected cells, there is an obvious refractory period after final repolarization is completed. Based on these measurements, the RRP increased 82% in HERG-overexpressing cells (32 ± 1 ms; n = 3) compared with controls (18 ± 3 ms; n = 4, P = 0.02). Changes in the RRP associated with levels of HERG channel expression may suggest novel cellular and molecular mechanisms by which to manipulate refractoriness.

HERG overexpression increases refractory period. The refractory period wasFigure 8

HERG overexpression increases refractory period. The refractory period was determined by interposing premature suprathreshold stimuli (115% of threshold) at varying intervals during periods of continuous AP stimulation. (a) In noninfected and AdGFP-infected myocytes, a second AP could be elicited before final repolarization to resting potential was complete. (b) An obvious refractory period persisted in AdHERG-infected myocytes after the membrane voltage returned to resting potential. To quantify the refractory period independent of differences in APD between groups, refractory period was measured from the APD90 of the first AP to the next stimulus that elicited a second normal AP. The refractory period increased by 82% because of HERG overexpression (n = 4, P = 0.02) compared with noninfected and AdGFP-infected controls (n = 3).

In summary, infection of adult rabbit ventricular myocytes with AdHERG produces selective enhancement of the E-4031–sensitive current. HERG overexpression abbreviates APs stimulated under physiologic conditions, and the degree of shortening correlates directly with the level of overexpression. In addition, EADs that are prevalent in cultured adult myocytes are suppressed by HERG overexpression and the refractory period is increased.

Discussion

We have introduced and overexpressed HERG in adult rabbit ventricular myocytes with the aim of determining the role that HERG/IKr plays in repolarization and suppression of EADs. The experimental approach was to create and use an adenoviral construct and to introduce HERG into adult cardiac myocytes. Rabbit myocytes were ideally suited for the purposes of this study because many of the electrophysiologic and pharmacologic properties of the endogenous currents have been characterized, including IKr and IKs (46–48). In addition, adult ventricular myocytes are easily maintained in short-term primary culture and infected with adenoviral constructs containing ion channel coding sequences with high efficiencies (27) .

Infection with AdHERG selectively enhanced the E-4031–sensitive current without affecting the density of Ito1. APs were abbreviated by more than 50% in HERG- overexpressing myocytes without obvious modification of the normal AP waveform. HERG overexpression in normal rabbit myocytes, which demonstrate frequent EADs when maintained in culture, effectively suppressed EADs and lengthened the refractory period. These results underscore the important role that HERG/IKr normally plays in cardiac excitability and how inherited HERG channel dysfunction can predispose to lethal cardiac arrhythmias.

Associations with β subunits or posttranslational modification unique to cardiac myocytes. The anomalously slow kinetics of HERG current when expressed in mammalian cells or oocytes (35) indicates that HERG alone, as the α subunit encoding IKr, does not accurately reproduce native IKr. We have found that HERG current kinetics are accelerated to normal values when expressed in cardiac myocytes, implicating potential associations of HERG with auxiliary β subunits, perhaps including minK (49), or posttranslational modifications of HERG unique to cardiac myocytes. Additionally, we have confirmed that the effect of physiologic temperature on HERG expressed in cardiac myocytes (this study) is similar to that reported for HERG expressed in HEK 293 cells (39): HERG gating kinetics are accelerated and more closely resemble endogenous IKr at physiologic temperatures.

The role of HERG/IKr current in repolarization. Zhou et al. (39) examined the role of HERG in AP repolarization experimentally by voltage clamping HERG-expressing HEK 293 cells and using a ventricular AP waveform as the command voltage. From these AP clamp experiments, Zhou et al. (39) found that HERG current activates rapidly following the upstroke of the AP, increases during repolarization, reaches a maximum during phases 2 and 3 of the AP, and continues to contribute outward current even after membrane voltage returns to resting potential. This behavior of HERG/IKr current during repolarization is unique to cardiac potassium channels and results from their unusual gating behavior — rapid recovery from inactivation and slow deactivation of the channels. This may explain why adenovirally mediated HERG overexpression so effectively suppressed the phase 2 EADs common to cultured adult cardiac myocytes while increasing the refractory period.

Viral gene transfer: bridging the gap between molecular biology and electrophysiology. This study proves that viral gene transfer can be used as an interventional approach to establish whether a particular abnormality reproduces all or part of the electrical phenotype of failing heart cells. Heart failure studies typically fall into one of two catagories: electrophysiologic studies that identify alterations in cellular currents, and molecular studies that report changes in expression of a given channel gene. To strengthen the etiologic links between the molecular and electrophysiologic alterations, we sought experimental evidence for cause-and-effect relations between changes in HERG/IKr expression and electrophysiologic abnormalities common in heart failure. We took an interventional genetic approach to manipulate the level of expression of HERG and characterized the electrophysiologic consequences of such overexpression. Our findings substantiate the notion that HERG/IKr current is an important current for normal repolarization, helping to prevent initiation of arrhythmia and playing a role in establishing the refractory period.

Acknowledgments

This work was supported by the American Heart Association (Scientist Development Grant; to H.B. Nuss), the Markey Foundation (training grant; to D.C. Johns), and the Tanabe Seiyaku Co., Ltd. General laboratory support was provided by National Institutes of Health grant R37 HL-36957 (to E. Marbán).

References
  1. Sanguinetti, MC, Jurkiewicz, NK. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990. 96:195-215.
    View this article via: PubMed CrossRef Google Scholar
  2. Warmke, JW, Ganetzky, B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 1994. 91:3438-3442.
    View this article via: PubMed CrossRef Google Scholar
  3. Trudeau, MC, Warmke, JW, Ganetzky, B, Robertson, GA. HERG sequence correction [letter]. Science 1996. 272:1087.
    View this article via: PubMed Google Scholar
  4. Trudeau, MC, Warmke, JW, Ganetzky, B, Robertson, GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995. 269:92-95.
    View this article via: PubMed CrossRef Google Scholar
  5. Yang, WP, et al. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci USA 1997. 94:4017-4021.
    View this article via: PubMed CrossRef Google Scholar
  6. Wang, Q, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996. 12:17-23.
    View this article via: PubMed CrossRef Google Scholar
  7. Romey, G, et al. Molecular mechanism and functional significance of the minK control of the KvLQT1 channel activity. J Biol Chem 1997. 272:16713-16716.
    View this article via: PubMed CrossRef Google Scholar
  8. Curran, ME, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995. 80:795-803.
    View this article via: PubMed CrossRef Google Scholar
  9. Tanaka, T, et al. Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome. Circulation 1997. 95:565-567.
    View this article via: PubMed Google Scholar
  10. Benson, DW, et al. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation 1996. 93:1791-1795.
    View this article via: PubMed Google Scholar
  11. Satler, CA, et al. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome. Am J Med Genet 1996. 65:27-35.
    View this article via: PubMed CrossRef Google Scholar
  12. Satler, CA, Vesely, MR, Duggal, P, Ginsburg, GS, Beggs, AH. Multiple different missense mutations in the pore region of HERG in patients with long QT syndrome. Hum Genet 1998. 102:265-272.
    View this article via: PubMed CrossRef Google Scholar
  13. Honig, PK, Woosley, RL, Zamani, K, Conner, DP, Cantilena (Jr), LR. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992. 52:231-238.
    View this article via: PubMed Google Scholar
  14. Woosley, RL, Chen, Y, Freiman, JP, Gillis, RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993. 269:1532-1536.
    View this article via: PubMed CrossRef Google Scholar
  15. Wysowski, DK, Bacsanyi, J. Cisapride and fatal arrhythmia [letter]. N Engl J Med 1996. 335:290-291.
    View this article via: PubMed CrossRef Google Scholar
  16. Bran, S, Murray, WA, Hirsch, IB, Palmer, JP. Long QT syndrome during high-dose cisapride. Arch Intern Med 1995. 155:765-768.
    View this article via: PubMed CrossRef Google Scholar
  17. Suessbrich, H, Waldegger, S, Lang, F, Busch, AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 1996. 385:77-80.
    View this article via: PubMed CrossRef Google Scholar
  18. Drolet, B, Khalifa, M, Daleau, P, Hamelin, BA, Turgeon, J. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation 1998. 97:204-210.
    View this article via: PubMed Google Scholar
  19. Li, GR, Feng, J, Yue, L, Carrier, M, Nattel, S. Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. Circ Res 1996. 78:689-696.
    View this article via: PubMed Google Scholar
  20. Noble, D, Varghese, A, Kohl, P, Noble, P. Improved guinea-pig ventricular cell model incorporating a diadic space, IKr and IKs, and length- and tension-dependent processes. Can J Cardiol 1998. 14:123-134.
    View this article via: PubMed Google Scholar
  21. Zeng, J, Laurita, KR, Rosenbaum, DS, Rudy, Y. Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization. Circ Res 1995. 77:140-152.
    View this article via: PubMed Google Scholar
  22. Priebe, L, Beuckelmann, DJ. Simulation study of cellular electric properties in heart failure. Circ Res 1998. 82:1206-1223.
    View this article via: PubMed Google Scholar
  23. Silver, LH, Hemwall, EL, Marino, TA, Houser, SR. Isolation and morphology of calcium-tolerant feline ventricular myocytes. Am J Physiol 1983. 245:H891-H896.
    View this article via: PubMed Google Scholar
  24. Johns, DC, et al. Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability. J Clin Invest 1995. 96:1152-1158.
    View this article via: JCI PubMed Google Scholar
  25. Rizzuto, R, Brini, M, Pizzo, P, Murgia, M, Pozzan, T. Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Curr Biol 1995. 5:635-642.
    View this article via: PubMed CrossRef Google Scholar
  26. Reichel, C, et al. Enhanced green fluorescence by the expression of an Aequorea victoria green fluorescent protein mutant in mono- and dicotyledonous plant cells. Proc Natl Acad Sci USA 1996. 93:5888-5893.
    View this article via: PubMed CrossRef Google Scholar
  27. Nuss, HB, et al. Reversal of potassium channel deficiency in cells from failing hearts by adenoviral gene transfer: a prototype for gene therapy for disorders of cardiac excitability and contractility. Gene Ther 1996. 3:900-912.
    View this article via: PubMed Google Scholar
  28. Hamill, OP, Marty, A, Neher, E, Sakmann, B, Sigworth, FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981. 391:85-100.
    View this article via: PubMed CrossRef Google Scholar
  29. Mitcheson, JS, Hancox, JC, Levi, AJ. Action potentials, ion channel currents and transverse tubule density in adult rabbit ventricular myocytes maintained for 6 days in cell culture. Pflugers Arch 1996. 431:814-827.
    View this article via: PubMed Google Scholar
  30. Jurkiewicz, NK, Sanguinetti, MC. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Circ Res 1993. 72:75-83.
    View this article via: PubMed Google Scholar
  31. Beatch, GN, Davis, DR, Laganiere, S, Williams, BA. Rate-dependent effects of sematilide on ventricular monophasic action potential duration and delayed rectifier K+ current in rabbits. J Cardiovasc Pharmacol 1996. 28:618-630.
    View this article via: PubMed CrossRef Google Scholar
  32. Patterson, E, Scherlag, BJ, Szabo, B, Lazzara, R. Facilitation of epinephrine-induced afterdepolarizations by class III antiarrhythmic drugs. J Electrocardiol 1997. 30:217-224.
    View this article via: PubMed CrossRef Google Scholar
  33. Jurkiewicz, NK, Wang, J, Fermini, B, Sanguinetti, MC, Salata, JJ. Mechanism of action potential prolongation by RP 58866 and its active enantiomer, terikalant. Block of the rapidly activating delayed rectifier K+ current, IKr. Circulation 1996. 94:2938-2946.
    View this article via: PubMed Google Scholar
  34. Snyders, DJ, Chaudhary, A. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 1996. 49:949-955.
    View this article via: PubMed Google Scholar
  35. Sanguinetti, MC, Jiang, C, Curran, ME, Keating, MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995. 81:299-307.
    View this article via: PubMed CrossRef Google Scholar
  36. Yang, T, Snyders, DJ, Roden, DM. Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells. Circ Res 1997. 80:782-789.
    View this article via: PubMed Google Scholar
  37. Wang, S, Morales, MJ, Liu, S, Strauss, HC, Rasmusson, RL. Time, voltage and ionic concentration dependence of rectification of HERG expressed in Xenopus oocytes. FEBS Lett 1996. 389:167-173.
    View this article via: PubMed CrossRef Google Scholar
  38. Wang, S, Morales, MJ, Liu, S, Strauss, HC, Rasmusson, RL. Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation. FEBS Lett 1997. 417:43-47.
    View this article via: PubMed CrossRef Google Scholar
  39. Zhou, Z, et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 1998. 74:230-241.
    View this article via: PubMed Google Scholar
  40. Beuckelmann, DJ, Nabauer, M, Erdmann, E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993. 73:379-385.
    View this article via: PubMed Google Scholar
  41. Liu, S, Rasmusson, RL, Campbell, DL, Wang, S, Strauss, HC. Activation and inactivation kinetics of an E-4031–sensitive current from single ferret atrial myocytes. Biophys J 1996. 70:2704-2715.
    View this article via: PubMed Google Scholar
  42. Follmer, CH, Colatsky, TJ. Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes. Circulation 1990. 82:289-293.
    View this article via: PubMed Google Scholar
  43. Nuss, HB, Kääb, S, Kass, DA, Tomaselli, GF, Marbán, E. Increased susceptibility to arrhythmogenic early afterdepolarizations and oscillatory prepotentials in failing canine ventricular myocytes. Circulation 1995. 92:I-434.
  44. Aizawa, Y, Uchiyama, H, Yamaura, M, Nakayama, T, Arita, M. Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias. J Electrocardiol 1998. 31:117-123.
    View this article via: PubMed CrossRef Google Scholar
  45. Miller, C. The inconstancy of the human heart. Nature 1996. 379:767-768.
    View this article via: PubMed Google Scholar
  46. Salata, JJ, et al. IK of rabbit ventricle is composed of two currents: evidence for IKs. Am J Physiol 1996. 271:H2477-H2489.
    View this article via: PubMed Google Scholar
  47. Rozanski, GJ, Xu, Z, Whitney, RT, Murakami, H, Zucker, IH. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J Mol Cell Cardiol 1997. 29:721-732.
    View this article via: PubMed CrossRef Google Scholar
  48. Clay, JR, Ogbaghebriel, A, Paquette, T, Sasyniuk, BI, Shrier, A. A quantitative description of the E-4031–sensitive repolarization current in rabbit ventricular myocytes. Biophys J 1995. 69:1830-1837.
    View this article via: PubMed Google Scholar
  49. McDonald, TV, et al. A minK-HERG complex regulates the cardiac potassium current IKr. Nature 1997. 388:289-292.
    View this article via: PubMed CrossRef Google Scholar
Version history
  • Version 1 (March 15, 1999): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Introduction
  • Methods
  • Results
  • Discussion
  • Acknowledgments
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts